Laboratoire de Biologie Tissulaire et d'Ingénierie Thérapeutique (LBTI), UMR 5305, Université Lyon 1, Centre National de la Recherche Scientifique (CNRS), Institut de Biologie et Chimie des Protéines (IBCP), Lyon, France.
Institut de Recherche Biomédicale des Armées (IRBA), Département des Maladies Infectieuses, Brétigny-sur-Orge, France.
Trends Biotechnol. 2017 Aug;35(8):770-784. doi: 10.1016/j.tibtech.2017.05.005. Epub 2017 Jun 20.
Reconstructing functional skin after a wound remains a challenge due to the complexity of healing. In this regard, biocompatible nanoparticles (NPs) carrying and releasing bioactive drugs in a controlled and sustained manner may significantly improve the efficacy of wound therapies compared with current treatments. Topical administration of drug-loaded NPs allows optimal delivery to the dermis and improves product efficacy. Furthermore, associating NPs with scaffolds represents a new concept of 'dressing'. Experimental in vivo, ex vivo, and in vitro models have been developed in preclinical assays to evaluate the beneficial effects of nanoparticulate dressings. Drug-loaded NPs are promising tools for innovative wound healing treatment, especially with regard to their multifunctional properties.
由于愈合过程的复杂性,在创伤后重建功能性皮肤仍然是一个挑战。在这方面,具有生物相容性的纳米粒子(NPs)可以以可控和持续的方式携带和释放生物活性药物,与目前的治疗方法相比,这可能显著提高伤口治疗的效果。载药纳米粒子的局部给药可使药物最佳递送至真皮,并提高产品的疗效。此外,将 NPs 与支架相结合代表了一种“敷料”的新概念。已经在临床前研究中开发了实验性体内、体外和体外模型,以评估纳米粒子敷料的有益效果。载药纳米粒子是创新伤口愈合治疗的有前途的工具,尤其是它们的多功能特性。